Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -9.59
- Piotroski Score 2.00
- Grade Hold
- Symbol (GRNA)
- Company GreenLight Biosciences Holdings
- Price $0.30
- Changes Percentage (-0.03%)
- Change -$0
- Day Low $0.30
- Day High $0.30
- Year High $5.90
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in Medford, Massachusetts.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 08/13/2023
- Fiscal Year End N/A
- Average Stock Price Target $11.00
- High Stock Price Target $18.00
- Low Stock Price Target $4.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.12
- Trailing P/E Ratio -0.26741071428571
- Forward P/E Ratio -0.26741071428571
- P/E Growth -0.26741071428571
- Net Income $-167,055,000
